HIV drug resistance test earns top honors at Deans’ Challenge
May 28, 2014 - HIV is now considered a chronic but manageable infection with the proper medication, but 10% of patients every year develop resistance to the drugs they are prescribed. Now, an affordable and quick test for drug resistance developed at Harvard School of Public Health (HSPH) will enable health care providers to match patients with the most effective drugs earlier in their treatment program. This technology, and its developers' mission to bring it to low-resource countries where the need is greatest, earned top honors for team Aldatu Biosciences in the Deans' Health & Life Sciences Challenge.
Read Full Article: http://www.hsph.harvard.edu/news/features/hiv-drug-resistance-test-earns-top-honors-at-deans-challenge/
Harvard School of Public Health ( www.hsph.harvard.edu ) is dedicated to advancing the public's health through learning, discovery, and communication. More than 400 faculty members are engaged in teaching and training the 1,000-plus student body in a broad spectrum of disciplines crucial to the health and well being of individuals and populations around the world. Programs and projects range from the molecular biology of AIDS vaccines to the epidemiology of cancer; from risk analysis to violence prevention; from maternal and children's health to quality of care measurement; from health care management to international health and human rights. For more information on the school visit: http://www.hsph.harvard.edu .
Twitter: www.twitter.com/HarvardHSPH
Facebook: www.facebook.com/harvardpublichealth
You Tube: www.youtube.com/user/HarvardPublicHealth
Website: www.hsph.harvard.edu
###
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News
|
